Page last updated: 2024-08-16

ribavirin and hcv 796

ribavirin has been researched along with hcv 796 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Chaudhary, I; Collett, M; Douglas, D; Gao, T; Howe, AY; Immermann, F; Kneteman, NM; Lewis, J; Lund, G; Mercer, DF; O'Connell, J; Pevear, D; Speth, J; Tyrrell, DL; Villano, SA1
Buck, M; Feldstein, A; Kleiner, D; Kravetz, D1

Trials

1 trial(s) available for ribavirin and hcv 796

ArticleYear
HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.
    Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:3

    Topics: Animals; Antiviral Agents; Benzofurans; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Interferon alpha-2; Interferon-alpha; Liver; Mice; Mice, SCID; Polyethylene Glycols; Recombinant Proteins; Replicon; Ribavirin; Sulfonamides; Viral Nonstructural Proteins

2009

Other Studies

2 other study(ies) available for ribavirin and hcv 796

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Severe hepatocellular injury with apoptosis induced by a hepatitis C polymerase inhibitor.
    Journal of clinical gastroenterology, 2009, Volume: 43, Issue:4

    Topics: Antiviral Agents; Apoptosis; Benzofurans; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Interferons; Liver; Liver Diseases; Male; Middle Aged; Polyethylene Glycols; Ribavirin; Sulfonamides

2009